Core Insights - Southbound funds reduced their holdings in HeartCare Medical-B (02160.HK) by 28,000 shares on November 4, 2025, marking a total net reduction of 596,000 shares over the past five trading days [1] - Over the last 20 trading days, southbound funds have decreased their holdings by a total of 1,934,000 shares, indicating a consistent trend of selling [1] - As of now, southbound funds hold 110 million shares of HeartCare Medical-B, which represents 4.56% of the company's total issued ordinary shares [1] Trading Data Summary - On November 4, 2025, total shares held were 110 million, with a decrease of 28,000 shares, reflecting a change of -0.03% [2] - On November 3, 2025, total shares held remained at 110 million, with a decrease of 86,000 shares, reflecting a change of -0.08% [2] - On October 24, 2025, total shares held were 110 million, with a decrease of 109,000 shares, reflecting a change of -0.10% [2] - On October 21, 2025, total shares held were 111 million, with a decrease of 273,000 shares, reflecting a change of -0.25% [2] - On October 16, 2025, total shares held were 111 million, with a decrease of 100,000 shares, reflecting a change of -0.09% [2] Company Overview - HeartCare Medical Technology Co., Ltd. specializes in providing comprehensive medical solutions for treating structural heart diseases [2] - The company's main business involves the research and commercialization of transcatheter and surgical solutions in the field of structural heart disease [2] - The product pipeline includes transcatheter aortic valve implantation (TAVI) series products, AnchorMan left atrial appendage closure (LAAC) products, transcatheter mitral valve (TMV) products, transcatheter tricuspid valve (TTV) products, and surgical support products [2] - The company operates in both domestic and international markets [2]
心通医疗-B（02160.HK）：11月4日南向资金减持2.8万股